Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Because of these potential risks, working closely with a healthcare provider is crucial to ensure the treatment is both safe and effective
Real-world data shows 53.6% quit within one year and 72.2% within two
A large prospective cohort study that tracked over 1,700 patients demonstrated that patients who underwent a Roux-en-Y gastric bypass lost an excess 21% of their body mass normalized to their non-surgical matched controls at the 10 year point (corresponding to 35 kg (~77 lbs) greater weight loss)
The best outcomes occur when medication is paired with nutrition, activity, sleep, and follow-up coaching
Semaglutide joins liraglutide (Saxenda), which is another GLP-1 receptor agonist that was FDA-approved for weight management in 2014
US$ 24.07
US$ 29.00
US$ 27.91
US$ 21.96
US$ 29.00
